The role of genetic polymorphisms in cytochrome P450 and effects of tuberculosis co-treatment on the predictive value of CYP2B6 SNPs and on efavirenz plasma levels in adult HIV patients.
about
PharmGKB summary: Efavirenz pathway, pharmacokineticsCase report: Severe central nervous system manifestations associated with aberrant efavirenz metabolism in children: the role of CYP2B6 genetic variation.Cytochrome P450 pharmacogenetics in African populations: implications for public health.Personalized medicine for patients with MDR-TB.Pharmacogenetic considerations in the treatment of HIV.Pharmacokinetics of efavirenz in patients on antituberculosis treatment in high HIV and tuberculosis burden countries: a systematic review.
P2860
The role of genetic polymorphisms in cytochrome P450 and effects of tuberculosis co-treatment on the predictive value of CYP2B6 SNPs and on efavirenz plasma levels in adult HIV patients.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
The role of genetic polymorphi ...... levels in adult HIV patients.
@en
The role of genetic polymorphi ...... levels in adult HIV patients.
@nl
type
label
The role of genetic polymorphi ...... levels in adult HIV patients.
@en
The role of genetic polymorphi ...... levels in adult HIV patients.
@nl
prefLabel
The role of genetic polymorphi ...... levels in adult HIV patients.
@en
The role of genetic polymorphi ...... levels in adult HIV patients.
@nl
P2093
P1433
P1476
The role of genetic polymorphi ...... levels in adult HIV patients.
@en
P2093
Emile Bienvenu
Marelize Swart
Michael Ashton
P356
10.1016/J.ANTIVIRAL.2013.11.011
P577
2013-12-05T00:00:00Z